Food, Supplement Trans Fat Footnote Consumer Research Urged By FTC
This article was originally published in The Tan Sheet
FDA should conduct consumer research to determine if a proposed footnote statement on foods and dietary supplements containing trans fat would confuse the public "about the relative risk of saturated fat, cholesterol and trans fat," the Federal Trade Commission says
You may also be interested in...
A new FDA task force will propose a research agenda focused on determining how science-based nutrition information is best articulated to consumers, Commissioner Mark McClellan, MD/PhD, announced Dec. 18
FDA is seeking comments on the proposed use of a footnote statement on food and dietary supplement products containing trans fat that would advise consumers against excessive intake of the ingredient
Tolerable upper intake levels (UL) for vitamins and minerals generally should not be used in food and dietary supplement labeling, according to Council for Responsible Nutrition VP-Scientific & Regulatory Affairs Annette Dickinson, PhD